Trial Outcomes & Findings for Clinical Evaluation of An Approved Contact Lens (NCT NCT02760810)
NCT ID: NCT02760810
Last Updated: 2017-07-11
Results Overview
Tear film osmolarity was measured in each subject eye using the TearLab Osmolarity system. The instrument was placed gently into the lower lid temporal tear minuscus without simulating reflex tearing
COMPLETED
NA
31 participants
2-Week Follow-up
2017-07-11
Participant Flow
A total of 31 subjects were enrolled in this study. Of the enrolled subjects 1 did not meet the eligibility criteria and 30 were dispensed the study lens. Of the dispensed subjects 29 completed the study and 1 subject was discontinued from the study.
Participant milestones
| Measure |
Narafilcon A
All subjects wore the same lens throughout the study.
|
|---|---|
|
Overall Study
STARTED
|
30
|
|
Overall Study
COMPLETED
|
29
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
Narafilcon A
All subjects wore the same lens throughout the study.
|
|---|---|
|
Overall Study
Protocol Violation
|
1
|
Baseline Characteristics
Clinical Evaluation of An Approved Contact Lens
Baseline characteristics by cohort
| Measure |
Narafilcon A
n=30 Participants
All subjects wore the same lens throughout the study.
|
|---|---|
|
Age, Continuous
|
22.8 Years
STANDARD_DEVIATION 4.08 • n=5 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
11 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
18 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
12 Participants
n=5 Participants
|
|
Region of Enrollment
United Kingdom
|
30 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2-Week Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Tear film osmolarity was measured in each subject eye using the TearLab Osmolarity system. The instrument was placed gently into the lower lid temporal tear minuscus without simulating reflex tearing
Outcome measures
| Measure |
Narafilcon A
n=54 Eyes
All subjects wore the same lens throughout the study.
|
|---|---|
|
Tear Film Osmolarity
|
293.4 mOsm/L
Standard Deviation 9.50
|
SECONDARY outcome
Timeframe: 1-Week Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Tear film osmolarity was measured in each subject eye using the TearLab Osmolarity system. The instrument was placed gently into the lower lid temporal tear minuscus without simulating reflex tearing.
Outcome measures
| Measure |
Narafilcon A
n=54 Eyes
All subjects wore the same lens throughout the study.
|
|---|---|
|
Tear Film Osmolarity
|
294.4 mOsm/L
Standard Deviation 9.48
|
SECONDARY outcome
Timeframe: 1-Week Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Tear Film PH was measured using a 1mm Microglass electrode (Thermo Scientific Orion 9810BN) placed gently in lower temporal tear meniscus of non-Schirmer eye without simulating reflex tearing.
Outcome measures
| Measure |
Narafilcon A
n=27 Participants
All subjects wore the same lens throughout the study.
|
|---|---|
|
Tear Film PH
|
6.86 PH value
Standard Deviation 0.180
|
Adverse Events
Narafilcon A
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Andrea Le, OD, MBA - Manager, Global Medical Affairs
Johnson & Johnson Vision Care Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60